'Everybody is the smartest motherf—ker in the world if you live in the Silicon Valley.'
defining industry for being insular and arrogant, and San Francisco itself for pushing out tech.
“The attitudes. I mean, it’s just like, ‘We’re tech bros, we’re tech bros, of course we’re smarter,’” he added. “‘We went to Harvard, we went to MIT, we’re in tech. You just can’t hang, you don’t know what the f—k is going on.’ I do all I can not to let any of my investments work out of Silicon Valley.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mark Cuban: San Francisco's Woke Tech Industry Is 'Pretentious as F*ck'Comedian Bill Maher and billionaire Mark Cuban — both leftists who backed Joe Biden — had a discussion during Sunday's episode of Maher's Club Random podcast about how insufferable and 'pretentious as fuck' people are in San Francisco.
Read more »
George Santos defends lies in scathing Fox News interview: ‘Everybody wants to nitpick’“Guys, I'm Jew-ish. Remember I was raised Catholic,” Republican George Santos said on Tuesday, after claiming on the campaign trail that his grandparents fled the Holocaust. The representative-elect campaigned on being a successful Jewish businessman.
Read more »
Breakingviews - “Lifetime value” is Silicon Valley’s next buzzwordSo long, “total addressable market”. Farewell, “flywheel effect”. Silicon Valley has a new buzzword. As the cost of signing up new customers rises, “lifetime value” is set to become must-use jargon for technology executives, investors and analysts in 2023. Companies like Uber Technologies , DoorDash and Spotify Technology want shareholders to know they can squeeze more revenue out of users than it costs to recruit them. As with previously popular jargon, though, the idea can quickly get garbled.
Read more »
S.F. grocery delivery giant Instacart trims valuation - Silicon Valley Business JournalInstacart cut its meaty valuation back in March. Here's how much it's just trimmed it again. bayarea technews
Read more »
Gilead buys remaining rights to cancer immunotherapy drug from partner Jounce - Silicon Valley Business Journal$GILD buys out rights to early-stage $JNCE cancer drug as part of ongoing efforts to beef up its cancer drug pipeline.
Read more »